Clinical Trials Browser

Active not recruiting × Pancreatic Neoplasms × Temozolomide × Clear all

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT03351296 2024-05-08

BETTER2

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms